Verywell Health on MSN
Suboxone vs. Methadone: What’s the Difference?
Opioid use disorder, also known as opioid dependence, is a complex condition that can be challenging to treat, but recovery ...
The authors write "Suboxone is the brand name of combination of Buprenorphine and Naloxone, manufactured by Indivior, Inc., and used in the treatment of opioid dependence. In January of 2022, the FDA ...
Doctors say the medication is vital to fend off an onslaught of overdoses. Yet in recovery circles, there’s resistance. LYNNWOOD — At the clean-and-sober house on Larch Way, there’s no heroin allowed.
Buprenorphine is a prescription medication. It’s approved by the Food and Drug Administration (FDA) to treat opioid dependence in adults. Opioid dependence is also called opioid use disorder (OUD), ...
Lev Facher covers the U.S. addiction and overdose crisis. Patients who received higher doses of buprenorphine, a common medication used to alleviate opioid withdrawal and cravings, were less likely to ...
Indivior, a pharmaceutical company, has reached a $30 million settlement to resolve a class action lawsuit filed in a U.S. court by health plans. The lawsuit alleges that the company unlawfully ...
Medicare plans are replacing brand-name buprenorphine-naloxone film with its generic equivalents, resulting in a decrease in out-of-pocket cost faced by enrollees with opioid use disorder. Objectives: ...
The practioners at Clear Path Clinic see the value in having a team of people provide primary care and addiction services under one roof. We have seen this approach change the lives of many patients ...
Buprenorphine, an important drug in fighting the opioid crisis, has long been closely monitored over concerns it would be abused. But a first-of-its-kind government oversight report released Thursday ...
PHILADELPHIA (AP) — The company that makes the opioid addiction treatment drug Suboxone has agreed to pay $102.5 million to 41 states and the District of Columbia to settle claims that the company ...
University of Houston (UH) researchers were awarded $1.4 million to eliminate dental problems that have been linked with buprenorphine, a prescription pain medication that has been shown to reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results